Section Arrow
Quote
FNCH.NASDAQ
- Finch Therapeutics Group
(Financial Status)
Quotes are at least 15-min delayed:2024/05/18 10:14 EDT
Last
 1.94
+0.02 (+1.04%)
Day High 
2.0427 
Prev. Close
1.92 
1-M High
3.13 
Volume 
9.29K 
Bid
1.9
Ask
2.02
Day Low
1.9216 
Open
1.93 
1-M Low
1.87 
Market Cap 
3.08M 
Currency USD 
P/E -- 
%Yield 0 
10-SMA 2.07 
20-SMA 2.21 
50-SMA 2.42 
52-W High 16.74 
52-W Low 1.86 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-9.81/-20.59
Enterprise Value
31.49M
Balance Sheet
Book Value Per Share
11.86
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
107.00K
Operating Revenue Per Share
0.16
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
NBYNovaBay Pharmaceuticals0.1186-0.0014-1.17%-- 
SCPXScorpius Holdings0.1035+0.0034+3.40%-- 
JAGXJaguar Health0.2585-0.0282-9.84%-- 
DNAGinkgo Bioworks Holdings0.8056-0.0334-3.98%-- 
ONCOOnconetix0.156+0.015+10.64%-- 
Quotes are at least 15-min delayed：2024/05/18 10:14 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Finch Therapeutics Group Inc is a microbiome technology company with a portfolio of intellectual property and microbiome assets. Finch has a robust intellectual property estate reflecting the company's pioneering role in the microbiome therapeutics field, including more than 70 issued U.S. and foreign patents with critical relevance for both donor-derived and donor-independent microbiome therapeutics in a range of potential indications. The company's assets include CP101, aninvestigational, orally administered microbiome candidate with positive clinical date from a Phase 2 randomized, placebo-controlled trial and a Phase 2 open-label trial in recurrent C. difficile infection (CDI).
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.